NeuroRx

A pharmaceutical company.

NeuroRx, Inc. is a clinical stage pharmaceutical company that is developing NRX-101, the first oral therapeutic for the treatment of Acute Suicidal Behavior/Ideation (ASIB) in Bipolar Disorder.The company is built upon 30 years of basic science and clinical expertise in understanding the role of the brain’s N-methyl-D-aspartate (NMDA) receptor in regulating human thought processes in general and in regulating depression and suicidality in specific. The company’s lead drug candidate is NRX-101 (Cyclurad), the first oral therapeutic for the treatment of Acute Suicidal Ideation/Behavior (ASIB) in Bipolar Depression.